Enovis Q3 Sales $559M, Raises Adjusted EBITDA/EPS Guidance, Adds $200M Buyback
ENOV sits 54% above its 52-week low of $16.7 on elevated volume (2.4× avg).
Summary
Enovis reported Q3 sales of $559 million (+2% reported, +5% organic) and raised full-year adjusted EBITDA and EPS guidance, while the Board approved a new $200 million share repurchase authorization.
Key Events · Earnings and Guidance · ENOV
-
Q3 Sales $559M, 5% Organic Growth
Net sales of $558.7 million rose 1.8% reported and 4.6% organic; Reconstructive grew 6.0% reported and 6.3% organic, while Prevention & Recovery fell 1.9% reported but grew 3.0% organic.
-
Adjusted EBITDA $103.5M, 18.5% Margin
Adjusted EBITDA of $103.5 million was 18.5% of sales versus 17.3% a year ago; GAAP net income was only $3.4 million (0.6% of sales) and adjusted EPS was $0.88.
-
Guidance Raised for EBITDA and EPS
Adjusted EBITDA guidance raised to $428-438 million from $425-435 million and adjusted EPS to $3.58-$3.79 from $3.52-$3.73; revenue narrowed to $2.32-2.35 billion from $2.31-2.37 billion.
-
New $200M Share Repurchase Authorization
The Board approved up to $200 million of buybacks, replacing the existing $100 million authorization; timing and amount depend on market conditions and capital allocation priorities.
Analysis · ENOV · Industrial Applications And Services
Third-quarter sales of $559 million grew 2% reported and 5% organic, with adjusted EPS of $0.88 and adjusted EBITDA of $103.5 million (18.5% of sales). The bigger news is the outlook: adjusted EBITDA guidance moves up to $428-438 million and adjusted EPS to $3.58-$3.79, even as revenue guidance narrows to $2.32-2.35 billion. The Board also approved a new $200 million repurchase authorization, replacing the prior $100 million program — a real capital-return signal for a company carrying $1.26 billion of debt and only $13 million of cash. GAAP net income was just $3 million, so the gap between adjusted and reported earnings remains wide.
How filings like this one have moved
In the 30 days to Nov 17, 2026, 38% of the 3791 measured filings Wiseek scored 7 moved their stock by 5% or more by the next session's close. The median move was 0.00%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, ENOV was trading at $25.77 on NYSE in the Industrial Applications And Services sector, with a market capitalization of approximately $1.4B. The 52-week trading range was $16.70 to $32.41. This filing was assessed with positive market sentiment and an importance score of 7 out of 10.